IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v505y2014i7484d10.1038_nature12893.html
   My bibliography  Save this article

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV

Author

Listed:
  • Mario Roederer

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Brandon F. Keele

    (SAIC-Frederick, Frederick National Laboratory, NIH, Frederick, Maryland 21702, USA)

  • Stephen D. Schmidt

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Rosemarie D. Mason

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Hugh C. Welles

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA
    George Washington University)

  • Will Fischer

    (Los Alamos National Laboratories)

  • Celia Labranche

    (Duke University)

  • Kathryn E. Foulds

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Mark K. Louder

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Zhi-Yong Yang

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA
    Present address: Sanofi-Pasteur, Cambridge, Massachusetts 02139, USA.)

  • John-Paul M. Todd

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Adam P. Buzby

    (Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center)

  • Linh V. Mach

    (Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center)

  • Ling Shen

    (Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center)

  • Kelly E. Seaton

    (Human Vaccine Institute, Duke University)

  • Brandy M. Ward

    (Duke University)

  • Robert T. Bailer

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Raphael Gottardo

    (Fred Hutchison Cancer Research Center)

  • Wenjuan Gu

    (Biostatistics Research Branch, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Guido Ferrari

    (Duke University)

  • S. Munir Alam

    (Human Vaccine Institute, Duke University)

  • Thomas N. Denny

    (Human Vaccine Institute, Duke University)

  • David C. Montefiori

    (Duke University)

  • Georgia D. Tomaras

    (Human Vaccine Institute, Duke University)

  • Bette T. Korber

    (Los Alamos National Laboratories)

  • Martha C. Nason

    (Biostatistics Research Branch, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Robert A. Seder

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Richard A. Koup

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Norman L. Letvin

    (Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center)

  • Srinivas S. Rao

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

  • Gary J. Nabel

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA
    Present address: Sanofi-Pasteur, Cambridge, Massachusetts 02139, USA.)

  • John R. Mascola

    (Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20892, USA)

Abstract

A major challenge for the development of a highly effective AIDS vaccine is the identification of mechanisms of protective immunity. To address this question, we used a nonhuman primate challenge model with simian immunodeficiency virus (SIV). We show that antibodies to the SIV envelope are necessary and sufficient to prevent infection. Moreover, sequencing of viruses from breakthrough infections revealed selective pressure against neutralization-sensitive viruses; we identified a two-amino-acid signature that alters antigenicity and confers neutralization resistance. A similar signature confers resistance of human immunodeficiency virus (HIV)-1 to neutralization by monoclonal antibodies against variable regions 1 and 2 (V1V2), suggesting that SIV and HIV share a fundamental mechanism of immune escape from vaccine-elicited or naturally elicited antibodies. These analyses provide insight into the limited efficacy seen in HIV vaccine trials.

Suggested Citation

  • Mario Roederer & Brandon F. Keele & Stephen D. Schmidt & Rosemarie D. Mason & Hugh C. Welles & Will Fischer & Celia Labranche & Kathryn E. Foulds & Mark K. Louder & Zhi-Yong Yang & John-Paul M. Todd &, 2014. "Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV," Nature, Nature, vol. 505(7484), pages 502-508, January.
  • Handle: RePEc:nat:nature:v:505:y:2014:i:7484:d:10.1038_nature12893
    DOI: 10.1038/nature12893
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature12893
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature12893?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fangzhu Zhao & Zachary T. Berndsen & Nuria PedreƱo-Lopez & Alison Burns & Joel D. Allen & Shawn Barman & Wen-Hsin Lee & Srirupa Chakraborty & Sandrasegaram Gnanakaran & Leigh M. Sewall & Gabriel Ozoro, 2022. "Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Svenja Weiss & Vincenza Itri & Ruimin Pan & Xunqing Jiang & Christina C. Luo & Lynn Morris & Delphine C. Malherbe & Philip Barnette & Jeff Alexander & Xiang-Peng Kong & Nancy L. Haigwood & Ann J. Hess, 2022. "Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:505:y:2014:i:7484:d:10.1038_nature12893. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.